{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:37:14Z","timestamp":1780763834810,"version":"3.54.1"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Studies reaffirm that familial hypercholesterolemia is more prevalent than initially considered, with a population frequency of approximately one in 300. The majority of patients remains unidentified. This warrants critical evaluation of existing screening methods and exploration of novel methods of detection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>New public policy recommendations on the detection of familial hypercholesterolemia have been made by a global community of experts and advocates. Phenotypic tools for diagnosing index cases remain inaccurate. Genetic testing is the gold standard for familial hypercholesterolemia and a new international position statement has been published. Correction of LDL cholesterol (LDL-C) for the cholesterol content of lipoprotein(a) [Lp(a)] may increase the precision of the phenotypic diagnosis of familial hypercholesterolemia. Cascade cotesting for familial hypercholesterolemia and elevated Lp(a) levels provides a new opportunity to stratify risk in families. Digital technology and machine learning methods, coupled with clinical alert and decision support systems, lead the way in more efficient approaches for detecting and managing index cases. Universal screening of children, combined with child-parent cascade testing, appears to be the most effective method for underpinning a population strategy for maximizing the detection of familial hypercholesterolemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Detection of familial hypercholesterolemia can be enhanced by optimizing current diagnostic algorithms, probing electronic health records with novel information technologies and integrating universal screening of children with cascade testing of parents and other relatives.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000714","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T10:01:33Z","timestamp":1602064893000},"page":"347-355","source":"Crossref","is-referenced-by-count":33,"title":["Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods"],"prefix":"10.1097","volume":"31","author":[{"given":"Shirin","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens F.","family":"Reeskamp","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.G.","family":"Stroes","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Crawley"},{"name":"Lipid Disorders Clinic, Cardiometabolic Service, Departments of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"R6-20230917","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCGENETICS.116.001381","article-title":"Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States: data from the CASCADE-FH Registry","volume":"9","author":"deGoma","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jamacardio.2019.5173","article-title":"Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action","volume":"5","author":"Wilemon","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jacc.2017.08.009","article-title":"Genetically confirmed familial hypercholesterolemia in patients with acute coronary syndrome","volume":"70","author":"Amor-Salamanca","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41569-019-0325-8","article-title":"Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care","volume":"17","author":"Watts","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hlc.2019.12.002","article-title":"Familial hypercholesterolaemia in 2020: a leading tier 1 genomic application","volume":"29","author":"Pang","year":"2020","journal-title":"Heart Lung Circ"},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MOL.0000000000000325","article-title":"Diagnostic scoring for familial hypercholesterolaemia in practice","volume":"27","author":"Haralambos","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MOL.0000000000000325","article-title":"Diagnostic scoring for familial hypercholesterolaemia in practice","volume":"27","author":"Haralambos","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"R14-20230917","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2014.12.034","article-title":"Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)","volume":"238","author":"Weng","year":"2015","journal-title":"Atherosclerosis"},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1016\/S2468-2667(19)30061-1","article-title":"Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care","volume":"4","author":"Weng","year":"2019","journal-title":"Lancet Public health"},{"key":"R17-20230917","first-page":"565","article-title":"Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia","volume":"38","author":"Besseling","year":"2017","journal-title":"Eur Heart J"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.cjca.2018.05.015","article-title":"Simplified Canadian definition for familial hypercholesterolemia","volume":"34","author":"Ruel","year":"2018","journal-title":"Can J Cardiol"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1210\/jc.2017-02622","article-title":"A comparative analysis of phenotypic predictors of mutations in familial hypercholesterolemia","volume":"103","author":"Chan","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"e000067","DOI":"10.1161\/HCG.0000000000000067","article-title":"Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association","volume":"13","author":"Musunuru","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jacl.2017.05.007","article-title":"Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: age- and gender-specific baseline lipid values and percentiles","volume":"11","author":"Balder","year":"2017","journal-title":"J Clin Lipidol"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R25-20230917","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1373\/clinchem.2019.306738","article-title":"Effect of lipoprotein(a) on the diagnosis of familial hypercholesterolemia: does it make a difference in the clinic?","volume":"65","author":"Chan","year":"2019","journal-title":"Clin Chem"},{"key":"R26-20230917","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2019.1518","article-title":"Identifying familial hypercholesterolemia using a blood donor screening program with more than 1 million volunteer donors","volume":"4","author":"Jackson","year":"2019","journal-title":"JAMA Cardiol"},{"key":"R27-20230917","doi-asserted-by":"crossref","DOI":"10.1177\/2047487319898951","article-title":"Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning","author":"Pina","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2589-7500(19)30150-5","article-title":"Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data","volume":"1","author":"Myers","year":"2019","journal-title":"Lancet Digital Health"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2020.07.022","article-title":"Electronic health records to facilitate continuous detection of familial hypercholesterolemia","volume":"310","author":"Pepplinkhuizen","year":"2020","journal-title":"Atherosclerosis"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.atherosclerosis.2018.06.012","article-title":"Establishing a national screening programme for familial hypercholesterolaemia in Lithuania","volume":"277","author":"Petrulioniene","year":"2018","journal-title":"Atherosclerosis"},{"key":"R31-20230917","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1177\/2047487317708890","article-title":"New data on familial hypercholesterolaemia and acute coronary syndromes: the promise of PCSK9 monoclonal antibodies in the light of recent clinical trials","volume":"24","author":"Ellis","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"R32-20230917","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jacl.2015.07.005","article-title":"Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit","volume":"9","author":"Pang","year":"2015","journal-title":"J Clin Lipidol"},{"key":"R33-20230917","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/clc.22880","article-title":"Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: between Scylla and Charybdis","volume":"41","author":"Ellis","year":"2018","journal-title":"Clin Cardiol"},{"key":"R34-20230917","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/2047487314533218","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"22","author":"Watts","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"R35-20230917","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.atherosclerosis.2018.08.019","article-title":"Screening for familial hypercholesterolaemia in primary care: time for general practice to play its part","volume":"277","author":"Brett","year":"2018","journal-title":"Atherosclerosis"},{"key":"R36-20230917","doi-asserted-by":"crossref","first-page":"e017817","DOI":"10.1136\/bmjopen-2017-017817","article-title":"An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the \u2018Ten Countries Study\u2019","volume":"7","author":"Pang","year":"2017","journal-title":"BMJ Open"},{"key":"R37-20230917","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.hlc.2013.08.005","article-title":"Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in Western Australia","volume":"23","author":"Bell","year":"2014","journal-title":"Heart Lung Circ"},{"key":"R38-20230917","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12687-018-0383-3","article-title":"Barriers to the identification of familial hypercholesterolemia among primary care providers","volume":"10","author":"Zimmerman","year":"2019","journal-title":"J Community Genet"},{"key":"R39-20230917","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.hlc.2014.09.011","article-title":"Systematic detection of familial hypercholesterolaemia in primary healthcare: a community based prospective study of three methods","volume":"24","author":"Kirke","year":"2015","journal-title":"Heart Lung Circ"},{"key":"R40-20230917","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/hrt.2006.107391","article-title":"Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre","volume":"94","author":"Gray","year":"2008","journal-title":"Heart"},{"key":"R41-20230917","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-156-4-201202210-00002","article-title":"Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: a matched-pair, cluster randomized trial","volume":"156","author":"Qureshi","year":"2012","journal-title":"Ann Intern Med"},{"key":"R42-20230917","doi-asserted-by":"crossref","first-page":"e81998","DOI":"10.1371\/journal.pone.0081998","article-title":"Availability and quality of coronary heart disease family history in primary care medical records: implications for cardiovascular risk assessment","volume":"9","author":"Dhiman","year":"2014","journal-title":"PLoS One"},{"key":"R43-20230917","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7326\/0000605-200912150-00177","article-title":"Systematic review: family history in risk assessment for common diseases","volume":"151","author":"Wilson","year":"2009","journal-title":"Ann Intern Med"},{"key":"R44-20230917","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.atherosclerosis.2014.04.002","article-title":"Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner","volume":"234","author":"Bell","year":"2014","journal-title":"Atherosclerosis"},{"key":"R45-20230917","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2013.03.027","article-title":"Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia","volume":"422","author":"Bell","year":"2013","journal-title":"Clin Chim Acta"},{"key":"R46-20230917","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajmg.a.34368","article-title":"The evaluation of cascade testing for familial hypercholesterolemia","volume":"158a","author":"Morris","year":"2012","journal-title":"Am J Med Genet A"},{"key":"R47-20230917","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2015.07.017","article-title":"Universal screening for familial hypercholesterolemia in children","volume":"66","author":"Klan\u010dar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R48-20230917","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2018.06.858","article-title":"Universal screening for familial hypercholesterolemia in children: the Slovenian model and literature review","volume":"277","author":"Groselj","year":"2018","journal-title":"Atherosclerosis"},{"key":"R49-20230917","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N Engl J Med"},{"key":"R50-20230917","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2019.11.028","article-title":"Reaching detection targets in familial hypercholesterolaemia: comparison of identification strategies","volume":"293","author":"Wald","year":"2020","journal-title":"Atherosclerosis"},{"key":"R51-20230917","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2018.05.047","article-title":"Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: a cost-utility analysis","volume":"275","author":"McKay","year":"2018","journal-title":"Atherosclerosis"},{"key":"R52-20230917","article-title":"Decision to reject screening for familial hypercholesterolaemia is flawed","author":"Wald","year":"2020"},{"key":"R53-20230917","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/s41436-018-0311-2","article-title":"Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia","volume":"21","author":"Alver","year":"2019","journal-title":"Genet Med"},{"key":"R54-20230917","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.2017.8543","article-title":"Cascade screening for familial hypercholesterolemia and the use of genetic testing","volume":"318","author":"Knowles","year":"2017","journal-title":"JAMA"},{"key":"R55-20230917","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet"},{"key":"R56-20230917","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2016.01.008","article-title":"Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up","volume":"67","author":"Perez de Isla","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R57-20230917","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jacc.2018.12.037","article-title":"Value of measuring lipoprotein(a) during cascade testing for familial hypercholesterolemia","volume":"73","author":"Ellis","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R58-20230917","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.atherosclerosissup.2017.05.019","article-title":"Cascade screening for familial hypercholesterolemia: practical consequences","volume":"30","author":"Louter","year":"2017","journal-title":"Atheroscler Suppl"},{"key":"R59-20230917","first-page":"244","article-title":"How disturbing is it to be approached for a genetic cascade screening programme for familial hypercholesterolaemia? Psychological impact and screenees\u2019 views","volume":"4","author":"van Maarle","year":"2001","journal-title":"Community Genet"},{"key":"R60-20230917","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacl.2017.01.002","article-title":"Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia","volume":"11","author":"L\u00e1zaro","year":"2017","journal-title":"J Clin Lipidol"},{"key":"R61-20230917","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/eurheartj\/ehx111","article-title":"Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK","volume":"38","author":"Kerr","year":"2017","journal-title":"Eur Heart J"},{"key":"R62-20230917","first-page":"464","article-title":"The cost-effectiveness of genetic screening for familial hypercholesterolemia: a systematic review","volume":"29","author":"Rosso","year":"2017","journal-title":"Ann Ig"},{"key":"R63-20230917","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2014.05.008","article-title":"Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia","volume":"8","author":"Ademi","year":"2014","journal-title":"J Clin Lipidol"},{"key":"R64-20230917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.05.007","article-title":"Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment?","volume":"304","author":"Ademi","year":"2020","journal-title":"Atherosclerosis"},{"key":"R65-20230917","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2018.05.021","article-title":"Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales","volume":"275","author":"Crosland","year":"2018","journal-title":"Atherosclerosis"},{"key":"R66-20230917","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.atherosclerosis.2018.01.036","article-title":"The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland","volume":"270","author":"Pelczarska","year":"2018","journal-title":"Atherosclerosis"},{"key":"R67-20230917","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2015.09.021","article-title":"Familial hypercholesterolaemia: a global call to arms","volume":"243","author":"Vallejo-Vaz","year":"2015","journal-title":"Atherosclerosis"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T07:08:44Z","timestamp":1694934524000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000714","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]}}}